Science Explorer Back to mapMap
Discussion
Company · Langen · Germany

Macopharma (Germany)

macopharma.com/enROR OpenAlex
Research works
8
▲ 115% vs 2018-21
Citations
221
28.4 per fractional work
Top-10% rate
12.3%
all institutions 10.0%
Open access
43%
world 40%
International
75%
world 18%
Macopharma (Germany)

Not ranked overall: Macopharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Macopharma (Germany) work in?

In all years, 60% of research at Macopharma (Germany) is in Health Sciences, 20% in Physical Sciences. Its largest fields are Medicine (58%), Engineering (18%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 59.9% of its workMedicine: 5 fractional works · 58.5% of its workBiochemistry: 1 fractional works · 17.0% of its workHematology: 1 fractional works · 13.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 6.9% of its workUrology: 0 fractional works · 6.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 3.1% of its workOncology: 0 fractional works · 2.8% of its workPhysiology: 0 fractional works · 2.2% of its workSurgery: 0 fractional works · 2.2% of its workEpidemiology: 0 fractional works · 1.7% of its workOphthalmology: 0 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workInfectious Diseases: 0 fractional works · 0.9% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.4% of its workOccupational Therapy: 0 fractional works · 1.4% of its workPhysical Sciences: 2 fractional works · 20.3% of its workEngineering: 1 fractional works · 18.3% of its workAutomotive Engineering: 1 fractional works · 9.6% of its workMechanical Engineering: 0 fractional works · 4.2% of its workBiomedical Engineering: 0 fractional works · 2.2% of its workBuilding and Construction: 0 fractional works · 1.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.0% of its workMaterials Science: 0 fractional works · 1.0% of its workPolymers and Plastics: 0 fractional works · 1.0% of its workLife Sciences: 1 fractional works · 11.3% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 9.1% of its workMolecular Biology: 0 fractional works · 5.0% of its workCell Biology: 0 fractional works · 1.5% of its workGenetics: 0 fractional works · 1.4% of its workBiophysics: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 2.2% of its workImmunology: 0 fractional works · 2.2% of its workSocial Sciences: 1 fractional works · 8.5% of its workBusiness, Management and Accounting: 1 fractional works · 8.5% of its workManagement of Technology and Innovation: 1 fractional works · 8.5% of its workALL ITS WORKMacopharma(Germany)8fractional works, all years
Life Sciences11%Physical Sciences20%Health Sciences60%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine558.5%
    2. Health Professions01.4%
    1. Engineering118.3%
    2. Environmental Science01.0%
    3. Materials Science01.0%
    1. Biochemistry, Genetics and Molecular Biology19.1%
    2. Immunology and Microbiology02.2%
    1. Business, Management and Accounting18.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Engineering: 4.20× its world share, 1 worksEngineeringEnvironmental Science: 0.79× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.13× its world share, 0 worksMaterials ScienceHealth Professions: 1.99× its world share, 0 worksHealth ProfessionsMedicine: 0.85× its world share, 0 worksMedicineBusiness, Management and Accounting: 2.31× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Engineering, 4.2×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Engineering4.20×1 works
  2. Business, Management and Accounting2.31×0 works
  3. Health Professions1.99×0 works
  4. Materials Science1.13×0 works
  5. Medicine0.85×0 works
  6. Environmental Science0.79×0 works

Who are the top researchers at Macopharma (Germany)?

Ranked on the quality score, Stefan Reichenberg lead among researchers whose main affiliation is Macopharma (Germany).

  1. 1 Stefan Reichenberg Germany · #2,617,614 worldwide 785 citations · 35 works
All ranked researchers at Macopharma (Germany)

What are the most cited papers from Macopharma (Germany)?

The most cited paper from Macopharma (Germany) is "Phenothiazinium derivatives for pathogen inactivation in blood products" (MARK S. WAINWRIGHT, H. Mohr, Wolfram H. Walker, 2006), with 128 citations. Next come "Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively" (123) and "Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction" (81).

Most cited papers
#PaperReleasedCitations
1 Phenothiazinium derivatives for pathogen inactivation in blood products MARK S. WAINWRIGHT, H. Mohr, Wolfram H. Walker · Journal of Photochemistry and Photobiology B Biology 19 Sep 2006 128
2 Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively Markus Eickmann, Ute Gravemann, Wiebke Handke et al. · Transfusion Open access 6 May 2018 123
3 Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction Jerard Seghatchian, Wilhelm G. Struff, Stefan Reichenberg · Transfusion Medicine and Hemotherapy Open access 2011 81
4 Humoral Immune Response Against Human Bocavirus VP2 Virus-Like Particles Juha Lindner, Lüdya Karalar, Sandra Zehentmeier et al. · Viral Immunology Dec 2008 76
5 Non‐phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags Linda Larsson, Per Sandgren, Sara Ohlsson et al. · Vox Sanguinis Open access 12 Sep 2020 48
All 23 most cited papers, with filters and sorting

Which research topics does Macopharma (Germany) publish most on?

By volume in 2022-now: Vehicle emissions and performance, Vehicle Dynamics and Control Systems, Transport Systems and Technology and Blood transfusion and management.

Vehicle emissions and performance: 0 fractional worksVehicle Dynamics and Control Systems: 0 fractional worksTransport Systems and Te…0Transport Systems and Technology: 0 fractional worksBlood transfusion and ma…0Blood transfusion and management: 0 fractional worksBlood donation and trans…0Blood donation and transfusion practices: 0 fractional worksInnovations in Concrete and Construction Materials: 0 fractional worksSafe Handling of Antineoplastic Drugs: 0 fractional worksPolymer Science and PVC: 0 fractional works3D Printing in Biomedical Research: 0 fractional worksAdditive Manufacturing and 3D Printing Technologies: 0 fractional works
Automotive EngineeringMechanical EngineeringBiochemistryManagement of Technology and Innovation4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Vehicle emissions and performance Automotive Engineering 0 works
  2. 2 Vehicle Dynamics and Control Systems Automotive Engineering 0 works
  3. 3 Transport Systems and Technology Mechanical Engineering 0 works
  4. 4 Blood transfusion and management Biochemistry 0 works
  5. 5 Blood donation and transfusion practices Management of Technology and Innovation 0 works
  6. 6 Innovations in Concrete and Construction Materials Building and Construction 0 works
  7. 7 Safe Handling of Antineoplastic Drugs Occupational Therapy 0 works
  8. 8 Polymer Science and PVC Polymers and Plastics 0 works
  9. 9 3D Printing in Biomedical Research Biomedical Engineering 0 works
  10. 10 Additive Manufacturing and 3D Printing Technologies Automotive Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.0%not open57.0%

World: 40% of research is openly available.

with international co-authors74.9%domestic only25.1%

World: 18% is written across borders.

How has Macopharma (Germany)'s research output changed?

Output in 2022-2025 was 115% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Macopharma (Germany) as a percentage of every work published that year, 0.000017% in 2023.

still counting0.000010%0.000020%0.000030%Macopharma (Germany)0.000017% in 202520102020

Fractional works of Macopharma (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Langen

All research institutions in Langen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Macopharma (Germany). Posts are plain text and can be reported.